YEREVAN. – “FMD K & L Europe,” an aftercare beneficiary of the Development Foundation of Armenia (DFA), has signed a memorandum of understanding with Swiss “Sylex” and “Clinerion” companies to promote biotechnology in Armenia.
In particular, the three companies will cooperate in promoting investments in biotechnology and clinical research in Armenia and investment of the best international practice, the DFA news service informed Armenian News-NEWS.am.
“The advanced technology, professional experience and capacity of our partners inspire confidence that this initiative will create new opportunities for industry development” stated “FMD K&L Europe” CEO Kirit Velani.
“The company's assessment of foreign investment is best expressed by bringing other foreign companies to Armenia, a good example of which is the trilateral program” mentioned DFA’s Aftercare team leader Hayk Mirzoyan.